期刊文献+

Fcγ受体ⅡA基因多态性与冠心病和扩张型心肌病的关系 被引量:3

Genetic Polymorphism of FcγRⅡA-Genes in Patients with Coronary Heart Disease and Dilated Cardiomyopathy
在线阅读 下载PDF
导出
摘要 目的炎症和免疫机制参与冠心病(CHD)和扩张型心肌病(DCM)的心肌损害。免疫球蛋白Fc受体(FcR)家族的FcγRⅡ参与免疫球蛋白介导的损伤过程,且与C反应蛋白结合,在炎症和免疫损害中起重要作用。有报道显示FcγRⅡ编码氨基酸131位置上的组氨酸(H/H)和精氨酸(R/R)多态性与某些炎症性和自身免疫性疾病有关。本研究旨在探讨该多态性与CHD和DCM的关系。方法正常对照组199名,冠脉造影证实的CHD患者324名,DCM患者116名,采用PCR和变性高效液相色谱仪分析(DHPLC)研究基因多态性。结果①按显性效应遗传模型分析(HH+HR与RR),DCM患者FcγRⅡA的H显性效应频率为0.92,较对照组0.78明显增高(P<0.001);②按加性效应遗传模型(HH与RR和HR与RR),DCM患者H加性效应频率也明显高于对照组(P<0.01和P<0.001);③DCM患者和对照组H等位基因频率分别为0.63和0.55,有显著性差异(P<0.05)。而CHD患者与对照组基因频率无显著差异。结论H等位基因可能是DCM患者的易感基因,但并不是冠心病的易感基因。 Objective To determine whether the polymorphism of FcγR Ⅱ A-Genes influences the risk of CHD and DCM. Methods The studied population consisted of 199 controls, 324 patients with angiographically documented CHD, and 116 patients with DCM. All subjects were genotyped by polymerase chain reaction and analyzed by denaturing high-performance liquid chromatography (DHPLC). Results ①Analysis of the genotype with respect to dominant effects of the H allele(HH + HR vs. RR) was 0.92 and 0.78 ,the individuals with the H allele had a significantly increased risk of DCM(P 〈0. 001 ) ;②Additive effects of the H allele (HH vs. RR and HR vs. RR)showed that also the individuals with the H allele had a significantly increased risk of DCM (P 〈0. 01 and P 〈0. 001 ) ; ③The H Allele frequencies of FcγR v A were 0.63 in the patients with DCM differing from those in the control subjects, which were 0.55 ( P 〈 0. 05 ), whereas no significant differences were observed between controls and CHD patients. Conclusion Our findings suggest that individuals with the H allele had a significantly increased risk of DCM, but not CHD.
出处 《国际遗传学杂志》 CAS 2006年第4期246-248,259,共4页 International Journal of Genetics
关键词 FCΓ RⅡA基因 多态性 冠心病 扩张型心肌病 FcγR Ⅱ A genes Polymorphism Coronary heart disease Dilated cardiomyopathy
  • 相关文献

参考文献12

  • 1Chirinos JA, Zambrano JP, Chakko S, et al. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Am J Cardiol, 2005,95:88 - 90.
  • 2Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, et al. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail, 2002,4:331 - 336.
  • 3Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol, 2005,25 :1359 - 1363.
  • 4Calverley DC, Brass E, Hacker MR, et al. Potential role of platelet Fcγ/RIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis, 2002,164:261 - 267.
  • 5Carcao MD, Blanchette VS, Wakefield CD, et al. Fcgamma receptor Ⅱ A and Ⅲ A polymorphisms in childhood immune thrombocytopenic purpura. Br J Haematol, 2003,120 : 135 - 141.
  • 6van de Winkel JG, van der Velden U. Fcgamma receptor polymorphisms in relation to periodontitis. J Clin Periodontol, 2003,30:595-602.
  • 7杜明,丰有吉.DHPLC和DDF检测散发性卵巢癌p53基因突变的应用[J].中国临床医学,2006,13(1):108-111. 被引量:5
  • 8Warmerdam PA, van de Winkel JG, Vlug A, et al. A single amino acid in the second Ig-like domain of the human Fc gamma receptor Ⅱ is critical for human IgG2 binding. J Immunol, 1991,147 : 1338 -1343.
  • 9Cooke GS, Aucan C, Walley AJ, et al. Association of Fcgamma receptor Ⅱ A (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg, 2003,69:565-568.
  • 10van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms.. Implications for function, disease susceptibility and immunotherapy. Tissue Antigens, 2003,61 : 189 - 202.

二级参考文献9

  • 1Kwok PY,Chen X.Detection of single nucleotide polymorphisms[J].Curr Issues Mol Biol,2003,5(2):43-60.
  • 2Yoon JH,Cho HI,Park SS,et al.Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria[J].J Clin Pathol,2002,55(6):410-413.
  • 3Lancaster JM,Berchuck A,Futreal PA,et al.Dideoxy fingerprinting assay for BRCA1 mutation analysis[J].Mol Carcinog,1997,19(3):176-179.
  • 4Lilleberg SL,Durocher J,Sanders C,et al.High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC,TP53,K-RAS,and BRAF genes with a novel DHPLC fluorescence detection platform[J].Ann N Y Ac ad Sci,2004,1022:250-256.
  • 5Knudson AG.Mutation and cancer:statistical study of retinoblastoma[J].Proc Natl Acad Sci U S A,1971,68(4):820-823.
  • 6Kurzawski G,Safranow K,Suchy J,et al.Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography[J].J Biochem Biophys Methods,2002,51 (1):89-100.
  • 7Gross E,Arnold N,Pfeifer K,et al.Identification of specific BRCA1and BRCA2 variants by DHPLC[J].Hum Mutat,2000,16(4):345-353.
  • 8Betz B,Florl AR,Seifert HH,et al.Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer[J].Hum Mutat,2004,23(6):612-620.
  • 9Jones AC,Sampson JR,Cheadle JP.Low level mosaicism detectable by DHPLC but not by direct sequencing[J].Hum Mutat,2001,17(3):233-234.

共引文献4

同被引文献39

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部